Storebrand Asset Management’s Pfizer PFE Stock Holding History

Storebrand Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$125M	Buy	5,190,196 +325,887	+7%	+$8.52M	0.31%	64
2026 Q1	$137M	Buy	4,864,309 +66,820	+1%	+$1.78M	0.39%	49
2025 Q4	$119M	Sell	4,797,489 -5,159	-0.1%	-$130K	0.32%	63
2025 Q3	$122M	Buy	4,802,648 +159,247	+3%	+$3.93M	0.32%	62
2025 Q2	$113M	Buy	4,643,401 +165,310	+4%	+$3.86M	0.33%	63
2025 Q1	$113M	Buy	4,478,091 +113,022	+3%	+$2.96M	0.37%	52
2024 Q4	$116M	Buy	4,365,069 +260,910	+6%	+$7.08M	0.35%	53
2024 Q3	$119M	Buy	4,104,159 +45,324	+1%	+$1.32M	0.37%	51
2024 Q2	$114M	Sell	4,058,835 -234,592	-5%	-$6.46M	0.38%	51
2024 Q1	$119M	Buy	4,293,427 +211,549	+5%	+$5.87M	0.41%	51
2023 Q4	$118M	Buy	4,081,878 +574,379	+16%	+$17.4M	0.42%	48
2023 Q3	$116M	Sell	3,507,499 -95,981	-3%	-$3.39M	0.55%	32
2023 Q2	$132M	Buy	3,603,480 +333,560	+10%	+$13M	0.6%	26
2023 Q1	$133M	Buy	3,269,920 +9,174	+0.3%	+$396K	0.68%	20
2022 Q4	$167M	Buy	3,260,746 +20,662	+0.6%	+$991K	0.92%	12
2022 Q3	$142M	Sell	3,240,084 -28,930	-0.9%	-$1.41M	0.86%	13
2022 Q2	$171M	Sell	3,269,014 -157,977	-5%	-$8.05M	0.97%	9
2022 Q1	$177M	Buy	3,426,991 +196,654	+6%	+$10.2M	0.84%	13
2021 Q4	$191M	Sell	3,230,337 -14,176	-0.4%	-$702K	0.85%	14
2021 Q3	$140M	Sell	3,244,513 -43,929	-1%	-$1.95M	0.68%	21
2021 Q2	$129M	Sell	3,288,442 -52,063	-2%	-$2.02M	0.63%	24
2021 Q1	$121M	Buy	3,340,505 +151,099	+5%	+$5.36M	0.64%	25
2020 Q4	$117M	Buy	3,189,406 +202,192	+7%	+$7.42M	0.7%	24
2020 Q3	$104M	Buy	2,987,214 +84,248	+3%	+$2.95M	0.75%	22
2020 Q2	$90.1M	Buy	2,902,966 +162,742	+6%	+$5.53M	0.74%	24
2020 Q1	$84.9M	Buy	+2,740,224	New	+$93.4M	0.88%	19

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Storebrand Asset Management's PFE Position: Q2 2026 in Review

Storebrand Asset Management increased its Pfizer (PFE) stake by 6.7% in Q2 2026, buying an estimated $8.52M and bringing the position to 5,190,196 shares worth $125M. The position accounts for 0.31% of the portfolio, ranked #64.

Storebrand Asset Management first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $191M in Q4 2021. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Storebrand Asset Management held 5,190,196 shares of Pfizer worth $125M as of Q2 2026.
Storebrand Asset Management bought 325,887 Pfizer shares in Q2 2026, an estimated $8.52M.
Pfizer made up 0.31% of Storebrand Asset Management's portfolio in Q2 2026, its #64 holding.
Storebrand Asset Management first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
Storebrand Asset Management's Pfizer position peaked at $191M in Q4 2021.
2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.